Topic 428 "cloud-based liquid-biopsy platform for the cancer research data commons"
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91021C00023
- Awardee
-
Earlydiagnostics Inc. UEI SGJ1NZDE89G4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $395,918
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Pre-Solicitation · PHS20211 · Posted Jul 9, 2020
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Solicitation · Posted Jul 28, 2020
- Contract value 100% obligated
- $395,918.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 11 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Los Angeles, CA 90095, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $395,918 |
About this award
Earlydiagnostics Inc., doing business as Earlydx, was awarded a $395,918 firm fixed price contract by the National Institutes of Health National Cancer Institute under the Small Business Innovation Research program. The contract has a total small business set aside designation. Earlydx will provide cloud-based development of a liquid-biopsy platform for the Cancer Research Data Commons, as requested in Topic 428 of the NIH/CDC SBIR solicitation seeking proposals for next generation technologies to advance biomedical and public health research. No major subcontractors were identified for this effort to support the National Cancer Institute's mission to advance cancer research.
Quick answers
Who was awarded contract 75N91021C00023?
75N91021C00023 was awarded to Earlydiagnostics Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2021.
How much is contract 75N91021C00023 worth?
The government has obligated $395,918 on 75N91021C00023.
Was contract 75N91021C00023 competed?
The extent of competition for 75N91021C00023 was full and open competition after exclusion of sources. The government received 11 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award